Oliguria in patients with normal renal function.

Erratum to: Failure of renal biomarkers to predict worsening renal function in high-risk patients presenting with oliguria.

Carbenicillin therapy in patients with normal and impaired renal function.

Acute renal failure without oliguria.

Pharmacokinetics of cefazolin patients with normal and impaired renal function.

Oliguria as an early indicator of mortality risk in patients with multiple myeloma and renal impairment.

Renal elimination of beta-2-microglobulin and myoglobin in patients with normal and impaired renal function.

Acute antihypertensive and renal effects of isradipine in hypertensive patients with normal and reduced renal function.

Cefepime-induced encephalopathy with normal renal function.

Renal decapsulation in the prevention of post-ischemic oliguria.

Neuromuscular block with doxacurium (BW A938U) in patients with normal or absent renal function.

Association of loop diuretic use with higher parathyroid hormone levels in patients with normal renal function.

Life-threatening hyperkalemia in a patient with normal renal function.

Warfarin-associated calciphylaxis in a patient with normal renal function.

Flucytosine kinetics in subjects with normal and impaired renal function.

Lomefloxacin pharmacokinetics in subjects with normal and impaired renal function.

Diabetes mellitus with normal renal function is associated with anaemia.

Renal function in normal and disordered pregnancy.

Selective elevation of monomeric IgA1 in IgA nephropathy patients with normal renal function.

Stereoselective pharmacokinetics of oral nitrendipine in elderly hypertensive patients with normal and impaired renal function.

Pharmacokinetics and pharmacodynamics of benazepril in hypertensive patients with normal and impaired renal function.

Is Serum Cystatin C a Predictor of Acute Pulmonary Thromboembolism in Patients With Normal Renal Function?

Monotherapy with labetalol for hypertensive patients with normal and impaired renal function.

Real-time urinary electrolyte monitoring after furosemide administration in surgical ICU patients with normal renal function.

Pharmacokinetics of cefamandole in patients with normal and impaired renal function.

Suggest Documents

Erratum to: Failure of renal biomarkers to predict worsening renal function in high-risk patients presenting with oliguria.

Carbenicillin therapy in patients with normal and impaired renal function.

Acute renal failure without oliguria.

Pharmacokinetics of cefazolin patients with normal and impaired renal function.

Oliguria as an early indicator of mortality risk in patients with multiple myeloma and renal impairment.

Renal elimination of beta-2-microglobulin and myoglobin in patients with normal and impaired renal function.

Acute antihypertensive and renal effects of isradipine in hypertensive patients with normal and reduced renal function.

Cefepime-induced encephalopathy with normal renal function.

Renal decapsulation in the prevention of post-ischemic oliguria.

Neuromuscular block with doxacurium (BW A938U) in patients with normal or absent renal function.

Association of loop diuretic use with higher parathyroid hormone levels in patients with normal renal function.

Life-threatening hyperkalemia in a patient with normal renal function.

Warfarin-associated calciphylaxis in a patient with normal renal function.

Flucytosine kinetics in subjects with normal and impaired renal function.

Lomefloxacin pharmacokinetics in subjects with normal and impaired renal function.

Diabetes mellitus with normal renal function is associated with anaemia.

Renal function in normal and disordered pregnancy.

Selective elevation of monomeric IgA1 in IgA nephropathy patients with normal renal function.

Stereoselective pharmacokinetics of oral nitrendipine in elderly hypertensive patients with normal and impaired renal function.

Pharmacokinetics and pharmacodynamics of benazepril in hypertensive patients with normal and impaired renal function.

Is Serum Cystatin C a Predictor of Acute Pulmonary Thromboembolism in Patients With Normal Renal Function?

Monotherapy with labetalol for hypertensive patients with normal and impaired renal function.

Real-time urinary electrolyte monitoring after furosemide administration in surgical ICU patients with normal renal function.

Pharmacokinetics of cefamandole in patients with normal and impaired renal function.

Oliguria in patients with normal renal function.

Recommend Documents

Follow Us